Do sugar-sweetened beverages cause adverse health outcomes in adults? A systematic review protocol

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Hamel, Candyce ^a   Stevens, Adrienne ^a   Singh, Kavita ^b   Ansari, Mohammed T ^a   Myers, Esther ^c   Ziegler, Paula ^d   Hutton, Brian ^a,e   Sharma, Arya ^e   Bjerre, Lise M ^f   Fenton, Shannon ^g   Lau, David C W ^h   O'Hara, Kathryn ⁱ   Reid, Robert ^j   Salewski, Erinn ^k   Shrier, Ian ^l   Willows, Noreen ^m   Tremblay, Mark ⁿ   Moher, David ^a,f  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c E F Myers Consulting Inc   (United States)

^d Academy of Nutrition and Dietetics   (United States)

^e ROYAL ALEXANDRA HOSPITAL   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ CARLETON UNIVERSITY   (Canada)

^j UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^k Healthy Living Section Chronic Disease and Injury Prevention Ottawa Public Health   (Canada)

^l MCGILL UNIVERSITY   (Canada)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

more..

Author keywords

Adult; Cancer; Cardiovascular disease; Chronic disease; Metabolic syndrome; Obesity; Sugar sweetened beverage; Systematic review; Type 2 diabetes

Indexed keywords

SUGAR; SUGAR INTAKE; SWEETENING AGENT;

ADULT; ADVERSE OUTCOME; ALCOHOLIC BEVERAGE; ARTICLE; BEVERAGE; BIBLIOGRAPHIC DATABASE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; DATA SYNTHESIS; DECISION MAKING; DENTAL CARIES; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GOUT; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INFORMATION RETRIEVAL; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RISK ASSESSMENT; SOFT DRINK; SUGAR SWEETENED BEVERAGE; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HEALTH EDUCATION; META ANALYSIS; METHODOLOGY; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC; SUGAR INTAKE;

BEVERAGES; CARDIOVASCULAR DISEASES; DENTAL CARIES; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; ENERGY INTAKE; GOUT; HEALTH EDUCATION; HUMANS; METABOLIC SYNDROME X; NEOPLASMS; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; SWEETENING AGENTS;

EID: 84920754679     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-108     Document Type: Article

References (72)

1. Pereira MA. The possible role of sugar-sweetened beverages in obesity etiology: a review of the evidence. Int J Obes (Lond) 2006, 30(Suppl 3):S28-S36.
2. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005, 2(1):5.
3. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002, 76(5):911-922.
4. Hung CT. Effects of high-fructose (90%) corn syrup on plasma glucose, insulin, and C-peptide in non-insulin-dependent diabetes mellitus and normal subjects. Taiwan Yi Xue Hui Za Zhi 1989, 88(9):883-885.
5. Klurfeld DM, Foreyt J, Angelopoulos TJ, Rippe JM. Lack of evidence for high fructose corn syrup as the cause of the obesity epidemic. Int J Obes (Lond) 2013, 37(6):771-773.
6. Melanson KJ, Zukley L, Lowndes J, Nguyen V, Angelopoulos TJ, Rippe JM. Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition 2007, 23(2):103-112.
7. Angelopoulos TJ, Lowndes J, Zukley L, Melanson KJ, Nguyen V, Huffman A, Rippe JM. The effect of high-fructose corn syrup consumption on triglycerides and uric acid. J Nutr 2009, 139(6):1242S-1245S.
8. Rippe JM, Kris Etherton PM. Fructose, sucrose, and high fructose corn syrup: modern scientific findings and health implications. Adv Nutr 2012, 3(5):739-740.
9. Grynbaum M. New York plans to ban sale of big sizes of sugary drinks. New York Times New York ed. 2012; May 30. pA1. [http://www.nytimes.com/2012/05/31/nyregion/bloomberg-plans-a-ban-on-large-sugared-drinks.html?pagewanted=all&_r=0].
10. World Health Organization WHO opens public consultation on draft sugars guideline. [http://www.who.int/mediacentre/news/notes/2014/consultation-sugar-guideline/en/], World Health Organization.
11. Han E, Powell LM. Consumption patterns of sugar-sweetened beverages in the United States. J Acad Nutr Diet 2013, 113(1):43-53.
12. Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121(11):1356-1364.
13. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33(11):2477-2483.
14. Hu FB, Malik VS. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 2010, 100(1):47-54.
15. Vartanian LR, Schwartz MB, Brownell KD. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health 2007, 97(4):667-675.
16. Gibson S. Sugar-sweetened soft drinks and obesity: a systematic review of the evidence from observational studies and interventions. Nutr Res Rev 2008, 21(2):134-147.
17. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006, 84(2):274-288.
18. World Health Organization Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series No. 916 2002, Geneva: World Health Organization, World Health Organization.
19. United States Department of Agriculture USDA's Nutrition Evidence Library. [http://www.nutritionevidencelibrary.gov/], United States Department of Agriculture.
20. Forshee RA, Anderson PA, Storey ML. Sugar-sweetened beverages and body mass index in children and adolescents: a meta-analysis. Am J Clin Nutr 2008, 87(6):1662-1671.
21. Mattes RD, Shikany JM, Kaiser KA, Allison DB. Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments. Obes Rev 2011, 12(5):346-365.
22. 5.3 Beverages. Int J Obes (Lond) 2009, 33:S28-S34.
23. Anderson GH. Sugars-containing beverages and post-prandial satiety and food intake. Int J Obes (Lond) 2006, 30:S52-S59.
24. Malik VS, Hu FB. Sugar-sweetened beverages and health: where does the evidence stand?. Am J Clin Nutr 2011, 94(5):1161-1162.
25. Weed DL, Althuis MD, Mink PJ. Quality of reviews on sugar-sweetened beverages and health outcomes: a systematic review. Am J Clin Nutr 2011, 94(5):1340-1347.
26. Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 2008, 168(14):1487-1492.
27. Ruxton CH, Gardner EJ, McNulty HM. Is sugar consumption detrimental to health? A review of the evidence 1995-2006. Crit Rev Food Sci Nutr 2010, 50(1):1-19.
28. de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr 2011, 93(6):1321-1327.
29. Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med 2012, 27(9):1127-1134.
30. Eshak ES, Iso H, Kokubo Y, Saito I, Yamagishi K, Inoue M, Tsugane S. Soft drink intake in relation to incident ischemic heart disease, stroke, and stroke subtypes in Japanese men and women: the Japan Public Health Centre-based study cohort I. Am J Clin Nutr 2012, 96(6):1390-1397.
31. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004, 15(5):615-625.
32. Cochrane Effective Practice and Organisation of Care Group What study designs should be included in an EPOC review and what should they be called?. [http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/05%20What%20study%20designs%20should%20be%20included%20in%20an%20EPOC%20review%202013%2008%2012.pdf], Cochrane Effective Practice and Organisation of Care Group.
33. Centers for Disease Control and Prevention The CDC guide to strategies for reducing the consumption of sugar-sweetened beverages. [http://www.cdph.ca.gov/SiteCollectionDocuments/StratstoReduce:Sugar_Sweetened_Bevs.pdf], Centers for Disease Control and Prevention.
34. Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 2009, 62(9):944-952.
35. Reuters T. Reference Manager 12 [Computer Program] 2011, New York: Thomson Reuters.
36. Partners E. DistillerSR [Computer Program] 2011, Ottawa: Evidence Partners.
37. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269. W64.
38. Higgins J, Altman DG. Chapter 8: assessing risk of bias in included studies. [http://handbook.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htm].
39. Higgins J, Altman DG. Chapter 16: special topics in statistics. [http://handbook.cochrane.org/].
40. Academy of Nutrition and Dietetics Appendix 8: quality criteria checklist: primary research. [http://www.andeal.org/evidence-analysis-manual], Academy of Nutrition and Dietetics.
41. Cochrane Effective Practice and Organisation of Care Group Suggested risk of bias criteria for EPOC reviews. [http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf], Cochrane Effective Practice and Organisation of Care Group.
42. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011, 64(4):401-406.
43. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol 2008, 8:70.
44. Pearl J. The art and science of cause and effect. Causality: Models, Reasoning and Inference 2000, 331-358. Cambridge: Cambridge University.
45. Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011, 22(5):745.
46. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 2006, 59(4):342-353.
47. Rosenthal R, Rosnow R, Rubin D. Contrasts and Effect Sizes in Behavioral Research: a Correlational Approach 2000, Cambridge: Cambridge University Press.
48. Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med 2000, 19(22):3127-3131.
49. Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ, Griffith L, Oremus M, Raina P, Ismaila A, Santaguida P, Lau J, Trikalinos TA. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol 2011, 64(11):1187-1197.
50. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis version 2. [http://www.meta-analysis.com/pages/downloads/Meta-Analysis-Manual.pdf].
51. SAS. [http://www.sas.com].
52. Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 2003, 19(4):613-623.
53. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
54. Arends LR, Hamza TH, van Houwelingen JC, Heijenbrok-Kal MH, Hunink MG, Stijnen T. Bivariate random effects meta-analysis of ROC curves. Med Decis Making 2008, 28(5):621-638.
55. Deeks JJ, Higgins J, Altman DG. Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series 2008, 243-296. Chichester: Wiley, Higgins JPT, Green S.
56. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
57. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011, 343:d4002.
58. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
59. Rucker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med 2008, 27(5):746-763.
60. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis 2009, New York: Wiley.
61. Moher D, Shamseer L, Clarke M. Reporting guidelines for systematic review protocols. 19th Cochrane Colloquium: 19-22 October 2011; Madrid
62. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007, 7:10.
63. Chow AW. Epidemiology, pathogenesis and clinical manifestations of odontogenic infections. [http://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-odontogenic-infections].
64. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004, 79(4):537-543.
65. Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol 2010, 21(12):2036-2039.
66. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009, 202(1):11-17.
67. Van Dam RM. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 2008, 33(6):1269-1283.
68. Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 2011, 51(4):363-373.
69. Center for Science in the Public Interest Petition to bar the use of caramel colorings produced with ammonia and containing the carcinogens 2-methylimidazole and 4-methylimidazole. [http://cspinet.org/new/pdf/caramel_coloring_petition.pdf], Center for Science in the Public Interest.
70. Tremblay MS, Colley RC, Saunders TJ, Healy GN, Owen N. Physiological and health implications of a sedentary lifestyle. Appl Physiol Nutr Metab 2010, 35(6):725-740.
71. Ware JE. SF-36® Health Survey Update. [http://www.sf-36.org/tools/SF36.shtml].
72. World Health Organization The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998, 46(12):1569-1585. World Health Organization.